Hendra virus and Nipah virus animal vaccines

Vaccine

Volumn 34, Issue 30, 2016, Pages 3525-3534

  Broder, Christopher C ^a   Weir, Dawn L ^b   Reid, Peter A ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Joint Base Pearl Harbor Hickam ^*  (United States)

^c Equine Veterinary Surgeon   (Australia)

Author keywords

Animal models; Antiviral; Hendra; Henipavirus; Monoclonal antibody; Nipah; Paramyxovirus; Pathogenesis; Vaccine

Indexed keywords

VIRUS VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; HENDRA VIRUS; HENDRA VIRUS INFECTION; HORSE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NIPAH VIRUS; NIPAH VIRUS INFECTION; NONHUMAN; PASSIVE IMMUNIZATION; PIG; PRIMATE; PRIORITY JOURNAL; VACCINATION; VETERINARY MEDICINE; VIRAL TROPISM; VIRUS ENTRY; ANIMAL; BAT; HENIPAVIRUS INFECTIONS; VETERINARY; ZOONOSES;

ANIMALS; CHIROPTERA; HENDRA VIRUS; HENIPAVIRUS INFECTIONS; HORSES; HUMANS; IMMUNIZATION, PASSIVE; NIPAH VIRUS; SWINE; VACCINATION; VIRAL VACCINES; ZOONOSES;

EID: 84966633286     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.075     Document Type: Article

References (158)

1. [1] Wang, L.-F., Mackenzie, J.S., Broder, C.C., Henipaviruses. Knipe, D.M., Howley, P.M., (eds.) Fields virology, 2013, Lippincott Williams & Wilkins, Philadelphia, 1070–1085.
2. [2] Marsh, G.A., de Jong, C., Barr, J.A., Tachedjian, M., Smith, C., Middleton, D., et al. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog, 8, 2012, e1002836.
3. [3] Clayton, B.A., Wang, L.F., Marsh, G.A., Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission. Zoonoses Public Health 60 (2013), 69–83.
4. [4] Wu, Z., Yang, L., Yang, F., Ren, X., Jiang, J., Dong, J., et al. Novel Henipa-like virus, Mojiang Paramyxovirus, in rats, China, 2012. Emerg Infect Dis 20 (2014), 1064–1066.
5. [5] Drexler, J.F., Corman, V.M., Muller, M.A., Maganga, G.D., Vallo, P., Binger, T., et al. Bats host major mammalian paramyxoviruses. Nat Commun, 3, 2012, 796.
6. [6] Abdullah, S., Tan, C.T., Henipavirus encephalitis. Handb Clin Neurol 123 (2014), 663–670.
7. [7] Wong, K.T., Ong, K.C., Pathology of acute henipavirus infection in humans and animals. Pathol Res Int, 2011, 2011, 567248.
8. [8] Playford, E.G., McCall, B., Smith, G., Slinko, V., Allen, G., Smith, I., et al. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis 16 (2010), 219–223.
9. [9] Wong, K.T., Tan, C.T., Clinical and pathological manifestations of human henipavirus infection. Curr Top Microbiol Immunol, 2012.
10. [10] Wong, K.T., Robertson, T., Ong, B.B., Chong, J.W., Yaiw, K.C., Wang, L.F., et al. Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathol Appl Neurobiol 35 (2009), 296–305.
11. [11] Broder, C.C., Xu, K., Nikolov, D.B., Zhu, Z., Dimitrov, D.S., Middleton, D., et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res 100 (2013), 8–13.
12. [12] Luby, S.P., The pandemic potential of Nipah virus. Antiviral Res 100 (2013), 38–43.
13. [13] Geisbert, T.W., Feldmann, H., Broder, C.C., Animal challenge models of henipavirus infection and pathogenesis. Curr Top Microbiol Immunol 359 (2012), 153–177.
14. [14] de Wit, E., Prescott, J., Falzarano, D., Bushmaker, T., Scott, D., Feldmann, H., et al. Foodborne transmission of nipah virus in Syrian hamsters. PLoS Pathog, 10, 2014, e1004001.
15. [15] Middleton, D., Pallister, J., Klein, R., Feng, Y.R., Haining, J., Arkinstall, R., et al. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health. Emerg Infect Dis 20 (2014), 372–379.
16. [16] Broder, C.C., Henipavirus outbreaks to antivirals: the current status of potential therapeutics. Curr Opin Virol 2 (2012), 176–187.
17. [17] Broder, C.C., Geisbert, T.W., Xu, K., Nikolov, D.B., Wang, L.F., Middleton, D., et al. Immunization strategies against henipaviruses. Curr Top Microbiol Immunol 359 (2012), 197–223.
18. [18] Murray, K., Rogers, R., Selvey, L., Selleck, P., Hyatt, A., Gould, A., et al. A novel morbillivirus pneumonia of horses and its transmission to humans. Emerg Infect Dis 1 (1995), 31–33.
19. [19] Hooper, P.T., Gould, A.R., Russell, G.M., Kattenbelt, J.A., Mitchell, G., The retrospective diagnosis of a second outbreak of equine morbillivirus infection. Aust Vet J 74 (1996), 244–245.
20. [20] Rogers, R.J., Douglas, I.C., Baldock, F.C., Glanville, R.J., Seppanen, K.T., Gleeson, L.J., et al. Investigation of a second focus of equine morbillivirus infection in coastal Queensland. Aust Vet J 74 (1996), 243–244.
21. [21] O'Sullivan, J.D., Allworth, A.M., Paterson, D.L., Snow, T.M., Boots, R., Gleeson, L.J., et al. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet 349 (1997), 93–95.
22. [22] ProMED-mail, Hendra virus, equine – Australia (12): (QL) vaccine. 2012, Pro-med: International Society for Infectious Diseases http://www.promedmail.org, archive no. 20121104.1390394.
23. [23] ProMED-mail, Hendra virus, equine – Australia (09): New South Wales dog affected. 2013, Promed: International Society for Infectious Diseases http://www.promedmail.org, archive no.20130721.1837123.
24. [24] ProMED-mail, Hendra virus, equine – Australia: (08) Queensland, New South Wales. 2013, Promed: International Society for Infectious Diseases http://www.promedmail.org, archive no.20130712.1820724.
25. [25] ProMED-mail, Hendra virus, equine – Australia (02): New South Wales. 2014, Pro-med:. International Society for Infectious Diseases http://www.promedmail.org, archive no. 20140621.2557020.
26. [26] ProMED-mail, Hendra virus, equine – Australia (03): Queensland. 2014, Pro-med: International Society for Infectious Diseases http://www.promedmail.org, archive no. 20140721.2626012.
27. [27] Hendra virus case confirmed after horse dies in North Queensland. 2015, Australian Broadcasting Corporation http://www.abc.net.au/news/2015-07-24/horse-dies-from-hendra-virus-northqueensland/6646178?.WT.ac=statenews_qld.
28. [28] ProMED-mail, Hendra virus, equine – Australia: New South Wales. 2015, Pro-med: International Society for Infectious Diseases http://www.promedmail.org, archive no. 20150625.3463123.
29. [29] ProMED-mail, Hendra virus, equine – Australia (04): New South Wales. 2015, Pro-med: International Society for Infectious Diseases http://www.promedmail.org, archive no.20150905.3625268.
30. [30] Plowright, R.K., Foley, P., Field, H.E., Dobson, A.P., Foley, J.E., Eby, P., et al. Urban habituation, ecological connectivity and epidemic dampening: the emergence of Hendra virus from flying foxes (Pteropus spp.). Proc R Soc B: Biol Sci 278 (2011), 3703–3712.
31. [31] Plowright, R.K., Eby, P., Hudson, P.J., Smith, I.L., Westcott, D., Bryden, W.L., et al. Ecological dynamics of emerging bat virus spillover. Proc R Soc B: Biol Sci, 282, 2015, 20142124.
32. [32] Field, H., Crameri, G., Kung, N.Y., Wang, L.F., Ecological aspects of hendra virus. Curr Top Microbiol Immunol 359 (2012), 11–23.
33. [33] Field, H.E., Breed, A.C., Shield, J., Hedlefs, R.M., Pittard, K., Pott, B., et al. Epidemiological perspectives on Hendra virus infection in horses and flying foxes. Aust Vet J 85 (2007), 268–270.
34. [34] ProMED-mail, Hendra virus, equine – Australia (21): (Queensland) canine. 2011, Pro-med: International Society for Infectious Diseases http://www.promedmail.org, archive no.20110802.2324.
35. [35] Kirkland, P.D., Gabor, M., Poe, I., Neale, K., Chaffey, K., Finlaison, D.S., et al. Hendra virus infection in dog, Australia, 2013. Emerg Infect Dis 21 (2015), 2182–2185.
36. [36] Anonymous, Outbreak of Hendra-like virus – Malaysia and Singapore, 1998–-1999. MMWR Morb Mortal Wkly Rep 48 (1999), 265–269.
37. [37] Chua, K.B., Goh, K.J., Wong, K.T., Kamarulzaman, A., Tan, P.S., Ksiazek, T.G., et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 354 (1999), 1257–1259.
38. [38] Chua, K.B., Bellini, W.J., Rota, P.A., Harcourt, B.H., Tamin, A., Lam, S.K., et al. Nipah virus: a recently emergent deadly paramyxovirus. Science 288 (2000), 1432–1435.
39. [39] Farrar, J.J., Nipah-virus encephalitis – investigation of a new infection. Lancet 354 (1999), 1222–1223.
40. [40] Paton, N.I., Leo, Y.S., Zaki, S.R., Auchus, A.P., Lee, K.E., Ling, A.E., et al. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet 354 (1999), 1253–1256.
41. [41] Chua, K.B., Nipah virus outbreak in Malaysia. J Clin Virol 26 (2003), 265–275.
42. [42] Pulliam, J.R., Epstein, J.H., Dushoff, J., Rahman, S.A., Bunning, M., Jamaluddin, A.A., et al. Agricultural intensification, priming for persistence and the emergence of Nipah virus: a lethal bat-borne zoonosis. J R Soc Interface 9 (2012), 89–101.
43. [43] Anonymous, Nipah encephalitis, human – Bangladesh (02). 2015, Pro-med: International Society for Infectious Diseases http://www.promedmail.org, archive no. 20150407.3280088.
44. [44] Rahman, M.A., Hossain, M.J., Sultana, S., Homaira, N., Khan, S.U., Rahman, M., et al. Date palm sap linked to Nipah virus outbreak in Bangladesh, 2008. Vector Borne Zoonotic Dis 12 (2012), 65–72.
45. [45] Homaira, N., Rahman, M., Hossain, M.J., Nahar, N., Khan, R., Podder, G., et al. Cluster of Nipah virus infection, Kushtia District, Bangladesh, 2007. PLoS One, 5, 2010, e13570.
46. [46] Homaira, N., Rahman, M., Hossain, M.J., Epstein, J.H., Sultana, R., Khan, M.S., et al. Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007. Epidemiol Infect 138 (2010), 1630–1636.
47. [47] Luby, S.P., Hossain, M.J., Gurley, E.S., Ahmed, B.N., Banu, S., Khan, S.U., et al. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001–2007. Emerg Infect Dis 15 (2009), 1229–1235.
48. [48] Luby, S.P., Gurley, E.S., Epidemiology of henipavirus disease in humans. Curr Top Microbiol Immunol 359 (2012), 25–40.
49. [49] Luby, S.P., Broder, C.C., Paramyxoviruses: henipaviruses. Kaslow, R.A., Stanberry, L.R., Le Duc, J.W., (eds.) Viral infections of humans, epidemiology and control, 2014, Springer Science + Business Media, New York, 519–536.
50. [50] Anonymous, Nipah encephalitis, human – Bangladesh (02). 2014, Pro-med: International Society for Infectious Diseases http://www.promedmail.org, archive no. 20140118.2181682.
51. [51] Halpin, K., Young, P.L., Field, H.E., Mackenzie, J.S., Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol 81 (2000), 1927–1932.
52. [52] Chua, K.B., Koh, C.L., Hooi, P.S., Wee, K.F., Khong, J.H., Chua, B.H., et al. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect 4 (2002), 145–151.
53. [53] Reynes, J.M., Counor, D., Ong, S., Faure, C., Seng, V., Molia, S., et al. Nipah virus in Lyle's flying foxes, Cambodia. Emerg Infect Dis 11 (2005), 1042–1047.
54. [54] Rahman, S.A., Hassan, S.S., Olival, K.J., Mohamed, M., Chang, L.Y., Hassan, L., et al. Characterization of Nipah virus from naturally infected Pteropus vampyrus bats, Malaysia. Emerg Infect Dis 16 (2010), 1990–1993.
55. [55] Middleton, D.J., Morrissy, C.J., van der Heide, B.M., Russell, G.M., Braun, M.A., Westbury, H.A., et al. Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus). J Comp Pathol 136 (2007), 266–272.
56. [56] Williamson, M.M., Hooper, P.T., Selleck, P.W., Gleeson, L.J., Daniels, P.W., Westbury, H.A., et al. Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses F cats. Aust Vet J 76 (1998), 813–818.
57. [57] Williamson, M.M., Hooper, P.T., Selleck, P.W., Westbury, H.A., Slocombe, R.F., Experimental hendra virus infection in pregnant guinea-pigs and fruit bats (Pteropus poliocephalus). J Comp Pathol 122 (2000), 201–207.
58. [58] Halpin, K., Hyatt, A.D., Fogarty, R., Middleton, D., Bingham, J., Epstein, J.H., et al. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg 85 (2011), 946–951.
59. [59] Hayman, D.T., Suu-Ire, R., Breed, A.C., McEachern, J.A., Wang, L., Wood, J.L., et al. Evidence of henipavirus infection in West African fruit bats. PLoS One, 3, 2008, e2739.
60. [60] Peel, A.J., Baker, K.S., Crameri, G., Barr, J.A., Hayman, D.T., Wright, E., et al. Henipavirus neutralising antibodies in an isolated island population of African fruit bats. PLoS One, 7, 2012, e30346.
61. [61] Peel, A.J., Sargan, D.R., Baker, K.S., Hayman, D.T., Barr, J.A., Crameri, G., et al. Continent-wide panmixia of an African fruit bat facilitates transmission of potentially zoonotic viruses. Nat Commun, 4, 2013, 2770.
62. [62] Hasebe, F., Thi Thu Thuy, N., Inoue, S., Yu, F., Kaku, Y., Watanabe, S., et al. Serologic evidence of Nipah virus infection in bats, Vietnam. Emerg Infect Dis 18 (2012), 536–537.
63. [63] Wacharapluesadee, S., Lumlertdacha, B., Boongird, K., Wanghongsa, S., Chanhome, L., Rollin, P., et al. Bat Nipah virus, Thailand. Emerg Infect Dis 11 (2005), 1949–1951.
64. [64] Li, Y., Wang, J., Hickey, A.C., Zhang, Y., Wu, Y., Zhang, H., et al. Antibodies to Nipah or Nipah-like viruses in bats, China. Emerg Infect Dis 14 (2008), 1974–1976.
65. [65] Drexler, J.F., Corman, V.M., Gloza-Rausch, F., Seebens, A., Annan, A., Ipsen, A., et al. Henipavirus RNA in African bats. PLoS One, 4, 2009, e6367.
66. [66] Ching, P.K., de Los Reyes, V.C., Sucaldito, M.N., Tayag, E., Columna-Vingno, A.B., Malbas, F.F. Jr., et al. Outbreak of henipavirus infection, Philippines, 2014. Emerg Infect Dis 21 (2015), 328–331.
67. [67] Pernet, O., Schneider, B.S., Beaty, S.M., LeBreton, M., Yun, T.E., Park, A., et al. Evidence for henipavirus spillover into human populations in Africa. Nat Commun, 5, 2014, 5342.
68. [68] Chowdhury, S., Khan, S.U., Crameri, G., Epstein, J.H., Broder, C.C., Islam, A., et al. Serological evidence of henipavirus exposure in cattle, goats and pigs in Bangladesh. PLoS Negl Trop Dis, 8, 2014, e3302.
69. [69] Hayman, D.T., Wang, L.F., Barr, J., Baker, K.S., Suu-Ire, R., Broder, C.C., et al. Antibodies to henipavirus or henipa-like viruses in domestic pigs in ghana, West Africa. PLoS One, 6, 2011, e25256.
70. [70] Hyatt, A.D., Zaki, S.R., Goldsmith, C.S., Wise, T.G., Hengstberger, S.G., Ultrastructure of Hendra virus and Nipah virus within cultured cells and host animals. Microbes Infect 3 (2001), 297–306.
71. [71] Goldsmith, C.S., Whistler, T., Rollin, P.E., Ksiazek, T.G., Rota, P.A., Bellini, W.J., et al. Elucidation of Nipah virus morphogenesis and replication using ultrastructural and molecular approaches. Virus Res 92 (2003), 89–98.
72. [72] Murray, K., Selleck, P., Hooper, P., Hyatt, A., Gould, A., Gleeson, L., et al. A morbillivirus that caused fatal disease in horses and humans. Science 268 (1995), 94–97.
73. [73] Wang, L.F., Yu, M., Hansson, E., Pritchard, L.I., Shiell, B., Michalski, W.P., et al. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol 74 (2000), 9972–9979.
74. [74] Marsh, G.A., Todd, S., Foord, A., Hansson, E., Davies, K., Wright, L., et al. Genome sequence conservation of Hendra virus isolates during spillover to horses, Australia. Emerg Infect Dis 16 (2010), 1767–1769.
75. [75] AbuBakar, S., Chang, L.Y., Ali, A.R., Sharifah, S.H., Yusoff, K., Zamrod, Z., Isolation and molecular identification of Nipah virus from pigs. Emerg Infect Dis 10 (2004), 2228–2230.
76. [76] Chan, Y.P., Chua, K.B., Koh, C.L., Lim, M.E., Lam, S.K., Complete nucleotide sequences of Nipah virus isolates from Malaysia. J Gen Virol 82 (2001), 2151–2155.
77. [77] Chua, K.B., Lek Koh, C., Hooi, P.S., Wee, K.F., Khong, J.H., Chua, B.H., et al. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect 4 (2002), 145–151.
78. [78] Harcourt, B.H., Tamin, A., Ksiazek, T.G., Rollin, P.E., Anderson, L.J., Bellini, W.J., et al. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology 271 (2000), 334–349.
79. [79] Harcourt, B.H., Lowe, L., Tamin, A., Liu, X., Bankamp, B., Bowden, N., et al. Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis 11 (2005), 1594–1597.
80. [80] Wacharapluesadee, S., Boongird, K., Wanghongsa, S., Ratanasetyuth, N., Supavonwong, P., Saengsen, D., et al. A longitudinal study of the prevalence of Nipah virus in Pteropus lylei bats in Thailand: evidence for seasonal preference in disease transmission. Vector Borne Zoonotic Dis 10 (2010), 183–190.
81. [81] Tanimura, N., Imada, T., Kashiwazaki, Y., Sharifah, S.H., Distribution of viral antigens and development of lesions in chicken embryos inoculated with nipah virus. J Comp Pathol 135 (2006), 74–82.
82. [82] Negrete, O.A., Wolf, M.C., Aguilar, H.C., Enterlein, S., Wang, W., Muhlberger, E., et al. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog, 2, 2006, e7.
83. [83] Negrete, O.A., Levroney, E.L., Aguilar, H.C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S., et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436 (2005), 401–405.
84. [84] Bonaparte, M.I., Dimitrov, A.S., Bossart, K.N., Crameri, G., Mungall, B.A., Bishop, K.A., et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 102 (2005), 10652–10657.
85. [85] Bishop, K.A., Stantchev, T.S., Hickey, A.C., Khetawat, D., Bossart, K.N., Krasnoperov, V., et al. Identification of hendra virus G glycoprotein residues that are critical for receptor binding. J Virol 81 (2007), 5893–5901.
86. [86] Drescher, U., Eph family functions from an evolutionary perspective. Curr Opin Genet Dev 12 (2002), 397–402.
87. [87] Bossart, K.N., Tachedjian, M., McEachern, J.A., Crameri, G., Zhu, Z., Dimitrov, D.S., et al. Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. Virology 372 (2008), 357–371.
88. [88] Gale, N.W., Baluk, P., Pan, L., Kwan, M., Holash, J., DeChiara, T.M., et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230 (2001), 151–160.
89. [89] Poliakov, A., Cotrina, M., Wilkinson, D.G., Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 7 (2004), 465–480.
90. [90] Pasquale, E.B., Eph-ephrin bidirectional signaling in physiology and disease. Cell 133 (2008), 38–52.
91. [91] Bossart, K.N., Crameri, G., Dimitrov, A.S., Mungall, B.A., Feng, Y.R., Patch, J.R., et al. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J Virol 79 (2005), 6690–6702.
92. [92] Bowden, T.A., Aricescu, A.R., Gilbert, R.J., Grimes, J.M., Jones, E.Y., Stuart, D.I., Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol 15 (2008), 567–572.
93. [93] Bowden, T.A., Crispin, M., Harvey, D.J., Aricescu, A.R., Grimes, J.M., Jones, E.Y., et al. Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design. J Virol, 2008.
94. [94] Bowden, T.A., Crispin, M., Harvey, D.J., Jones, E.Y., Stuart, D.I., Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol 84 (2010), 6208–6217.
95. [95] Xu, K., Rajashankar, K.R., Chan, Y.P., Himanen, J.P., Broder, C.C., Nikolov, D.B., Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci U S A 105 (2008), 9953–9958.
96. [96] Xu, K., Chan, Y.P., Rajashankar, K.R., Khetawat, D., Yan, L., Kolev, M.V., et al. New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with ephrin-B2. PLoS One, 7, 2012, e48742.
97. [97] Bossart, K.N., Fusco, D.L., Broder, C.C., Paramyxovirus entry. Adv Exp Med Biol 790 (2013), 95–127.
98. [98] Pager, C.T., Dutch, R.E., Cathepsin L is involved in proteolytic processing of the hendra virus fusion protein. J Virol 79 (2005), 12714–12720.
99. [99] Aguilar, H.C., Iorio, R.M., Henipavirus membrane fusion and viral entry. Curr Top Microbiol Immunol 359 (2012), 79–94.
100. [100] Lee, B., Ataman, Z.A., Modes of paramyxovirus fusion: a henipavirus perspective. Trends Microbiol 19 (2011), 389–399.
101. [101] Goh, K.J., Tan, C.T., Chew, N.K., Tan, P.S., Kamarulzaman, A., Sarji, S.A., et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med 342 (2000), 1229–1235.
102. [102] Mahalingam, S., Herrero, L.J., Playford, E.G., Spann, K., Herring, B., Rolph, M.S., et al. Hendra virus: an emerging paramyxovirus in Australia. Lancet Infect Dis 12 (2012), 799–807.
103. [103] Selvey, L.A., Wells, R.M., McCormack, J.G., Ansford, A.J., Murray, K., Rogers, R.J., et al. Infection of humans and horses by a newly described morbillivirus. Med J Aust 162 (1995), 642–645 [see comments].
104. [104] Taylor, C., Playford, E.G., McBride, W.J., McMahon, J., Warrilow, D., No evidence of prolonged Hendra virus shedding by 2 patients, Australia. Emerg Infect Dis 18 (2012), 2025–2027.
105. [105] Tan, C.T., Goh, K.J., Wong, K.T., Sarji, S.A., Chua, K.B., Chew, N.K., et al. Relapsed and late-onset Nipah encephalitis. Ann Neurol 51 (2002), 703–708.
106. [106] Wong, S.C., Ooi, M.H., Wong, M.N., Tio, P.H., Solomon, T., Cardosa, M.J., Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response. J Neurol Neurosurg Psychiatry 71 (2001), 552–554.
107. [107] Chong, H.T., Tan, C.T., Relapsed and late-onset Nipah encephalitis, a report of three cases. Neurol J Southeast Asia 8 (2003), 109–112.
108. [108] Tan, C.T., Wong, K.T., Nipah encephalitis outbreak in Malaysia. Ann Acad Med Singapore 32 (2003), 112–117.
109. [109] Abdullah, S., Chang, L.Y., Rahmat, K., Goh, K.T., Tan, C.T., Late-onset Nipah virus encephalitis 11 years after the initial outbreak: a case report. Neurol Asia 17 (2012), 71–74.
110. [110] Bellini, W.J., Harcourt, B.H., Bowden, N., Rota, P.A., Nipah virus: an emergent paramyxovirus causing severe encephalitis in humans. J Neurovirol 11 (2005), 481–487.
111. [111] Sejvar, J.J., Hossain, J., Saha, S.K., Gurley, E.S., Banu, S., Hamadani, J.D., et al. Long-term neurological and functional outcome in Nipah virus infection. Ann Neurol, 2007.
112. [112] Wong, K.T., Shieh, W.J., Kumar, S., Norain, K., Abdullah, W., Guarner, J., et al. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 161 (2002), 2153–2167.
113. [113] Hooper, P., Zaki, S., Daniels, P., Middleton, D., Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect 3 (2001), 315–322.
114. [114] Dhondt, K.P., Horvat, B., Henipavirus infections: lessons from animal models. Pathogens (Basel, Switzerland) 2 (2013), 264–287.
115. [115] Middleton, D.J., Weingartl, H.M., Henipaviruses in their natural animal hosts. Curr Top Microbiol Immunol 359 (2012), 105–121.
116. [116] Williamson, M.M., Hooper, P.T., Selleck, P.W., Westbury, H.A., Slocombe, R.F., A guinea-pig model of Hendra virus encephalitis. J Comp Pathol 124 (2001), 273–279.
117. [117] Westbury, H.A., Hooper, P.T., Selleck, P.W., Murray, P.K., Equine morbillivirus pneumonia: susceptibility of laboratory animals to the virus. Aust Vet J 72 (1995), 278–279.
118. [118] Guillaume, V., Wong, K.T., Looi, R.Y., Georges-Courbot, M.C., Barrot, L., Buckland, R., et al. Acute Hendra virus infection: analysis of the pathogenesis and passive antibody protection in the hamster model. Virology 387 (2009), 459–465.
119. [119] Wong, K.T., Grosjean, I., Brisson, C., Blanquier, B., Fevre-Montange, M., Bernard, A., et al. A golden hamster model for human acute Nipah virus infection. Am J Pathol 163 (2003), 2127–2137.
120. [120] Mungall, B.A., Middleton, D., Crameri, G., Bingham, J., Halpin, K., Russell, G., et al. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J Virol 80 (2006), 12293–12302.
121. [121] Middleton, D.J., Westbury, H.A., Morrissy, C.J., van der Heide, B.M., Russell, G.M., Braun, M.A., et al. Experimental Nipah virus infection in pigs and cats. J Comp Pathol 126 (2002), 124–136.
122. [122] Li, M., Embury-Hyatt, C., Weingartl, H.M., Experimental inoculation study indicates swine as a potential host for Hendra virus. Vet Res, 41, 2010, 33.
123. [123] Weingartl, H., Czub, S., Copps, J., Berhane, Y., Middleton, D., Marszal, P., et al. Invasion of the central nervous system in a porcine host by Nipah virus. J Virol 79 (2005), 7528–7534.
124. [124] Pallister, J., Middleton, D., Wang, L.F., Klein, R., Haining, J., Robinson, R., et al. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine 29 (2011), 5623–5630.
125. [125] Bossart, K.N., Zhu, Z., Middleton, D., Klippel, J., Crameri, G., Bingham, J., et al. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog, 5, 2009, e1000642.
126. [126] Rockx, B., Bossart, K.N., Feldmann, F., Geisbert, J.B., Hickey, A.C., Brining, D., et al. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol 84 (2010), 9831–9839.
127. [127] Geisbert, T.W., Daddario-DiCaprio, K.M., Hickey, A.C., Smith, M.A., Chan, Y.P., Wang, L.F., et al. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One, 5, 2010, e10690.
128. [128] Marianneau, P., Guillaume, V., Wong, T., Badmanathan, M., Looi, R.Y., Murri, S., et al. Experimental infection of squirrel monkeys with nipah virus. Emerg Infect Dis 16 (2010), 507–510.
129. [129] Marsh, G.A., Haining, J., Hancock, T.J., Robinson, R., Foord, A.J., Barr, J.A., et al. Experimental infection of horses with Hendra virus/Australia/horse/2008/Redlands. Emerg Infect Dis 17 (2011), 2232–2238.
130. [130] Mohd Nor, M.N., Gan, C.H., Ong, B.L., Nipah virus infection of pigs in peninsular Malaysia. Rev Sci Tech 19 (2000), 160–165.
131. [131] Field, H., Schaaf, K., Kung, N., Simon, C., Waltisbuhl, D., Hobert, H., et al. Hendra virus outbreak with novel clinical features, Australia. Emerg Infect Dis 16 (2010), 338–340.
132. [132] Hooper, P.T., Ketterer, P.J., Hyatt, A.D., Russell, G.M., Lesions of experimental equine morbillivirus pneumonia in horses. Vet Pathol 34 (1997), 312–322.
133. [133] Kong, D., Wen, Z., Su, H., Ge, J., Chen, W., Wang, X., et al. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Virology 432 (2012), 327–335.
134. [134] Kurup, D., Wirblich, C., Feldmann, H., Marzi, A., Schnell, M.J., Rhabdovirus-based vaccine platforms against henipaviruses. J Virol 89 (2015), 144–154.
135. [135] Wang, X., Ge, J., Hu, S., Wang, Q., Wen, Z., Chen, H., et al. Efficacy of DNA immunization with F and G protein genes of Nipah virus. Ann N Y Acad Sci 1081 (2006), 243–245.
136. [136] Walpita, P., Barr, J., Sherman, M., Basler, C.F., Wang, L., Vaccine potential of Nipah virus-like particles. PLoS One, 6, 2011, e18437.
137. [137] Guillaume, V., Contamin, H., Loth, P., Georges-Courbot, M.C., Lefeuvre, A., Marianneau, P., et al. Nipah virus: vaccination and passive protection studies in a hamster model. J Virol 78 (2004), 834–840.
138. [138] Weingartl, H.M., Berhane, Y., Caswell, J.L., Loosmore, S., Audonnet, J.C., Roth, J.A., et al. Recombinant nipah virus vaccines protect pigs against challenge. J Virol 80 (2006), 7929–7938.
139. [139] Ploquin, A., Szecsi, J., Mathieu, C., Guillaume, V., Barateau, V., Ong, K.C., et al. Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines. J Infect Dis 207 (2013), 469–478.
140. [140] Yoneda, M., Georges-Courbot, M.C., Ikeda, F., Ishii, M., Nagata, N., Jacquot, F., et al. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PLoS One, 8, 2013, e58414.
141. [141] Mire, C.E., Versteeg, K.M., Cross, R.W., Agans, K.N., Fenton, K.A., Whitt, M.A., et al. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virol J, 10, 2013, 353.
142. [142] DeBuysscher, B.L., Scott, D., Marzi, A., Prescott, J., Feldmann, H., Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine 32 (2014), 2637–2644.
143. [143] Lo, M.K., Bird, B.H., Chattopadhyay, A., Drew, C.P., Martin, B.E., Coleman, J.D., et al. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. Antiviral Res 101 (2014), 26–29.
144. [144] Colgrave, M.L., Snelling, H.J., Shiell, B.J., Feng, Y.R., Chan, Y.P., Bossart, K.N., et al. Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus. Glycobiology 22 (2011), 572–584.
145. [145] McEachern, J.A., Bingham, J., Crameri, G., Green, D.J., Hancock, T.J., Middleton, D., et al. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine 26 (2008), 3842–3852.
146. [146] Pallister, J.A., Klein, R., Arkinstall, R., Haining, J., Long, F., White, J.R., et al. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months. Virol J, 10, 2013, 237.
147. [147] Mire, C.E., Geisbert, J.B., Agans, K.N., Feng, Y.R., Fenton, K.A., Bossart, K.N., et al. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge. J Virol 88 (2014), 4624–4631.
148. [148] Australian Government, Australian Pesticides and Veterinary Medicines Authority – Summary of adverse experience reports made to the APVMA about Hendra virus vaccine. 2015 Available: http://apvma.gov.au/node/15786.
149. [149] Guillaume, V., Contamin, H., Loth, P., Grosjean, I., Courbot, M.C., Deubel, V., et al. Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol 80 (2006), 1972–1978.
150. [150] Zhu, Z., Dimitrov, A.S., Bossart, K.N., Crameri, G., Bishop, K.A., Choudhry, V., et al. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol 80 (2006), 891–899.
151. [151] Zhu, Z., Bossart, K.N., Bishop, K.A., Crameri, G., Dimitrov, A.S., McEachern, J.A., et al. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis 197 (2008), 846–853.
152. [152] Xu, K., Rockx, B., Xie, Y., Debuysscher, B.L., Fusco, D.L., Zhu, Z., et al. Crystal structure of the hendra virus attachment g glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. PLoS Pathog, 9, 2013, e1003684.
153. [153] Bossart, K.N., Geisbert, T.W., Feldmann, H., Zhu, Z., Feldmann, F., Geisbert, J.B., et al. A neutralizing human monoclonal antibody protects African green monkeys from Hendra virus challenge. Sci Transl Med, 3, 2011, 105ra3.
154. [154] Geisbert, T.W., Mire, C.E., Geisbert, J.B., Chan, Y.P., Agans, K.N., Feldmann, F., et al. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci Transl Med, 6, 2014, 242ra82.
155. [155] Government, Q., World-first Hendra treatment one step closer. 2013.
156. [156] Prescott, J., DeBuysscher, B.L., Feldmann, F., Gardner, D.J., Haddock, E., Martellaro, C., et al. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease. Vaccine 33 (2015), 2823–2829.
157. [157] Bossart, K.N., Rockx, B., Feldmann, F., Brining, D., Scott, D., Lacasse, R., et al. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Sci Transl Med, 4, 2012, 146ra07.
158. [158] Kelley, L.A., Sternberg, M.J., Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4 (2009), 363–371.